vs
Side-by-side financial comparison of ENvue Medical, Inc. (FEED) and Hyperliquid Strategies Inc (PURR). Click either name above to swap in a different company.
Hyperliquid Strategies Inc is the larger business by last-quarter revenue ($500.0K vs $312.0K, roughly 1.6× ENvue Medical, Inc.). ENvue Medical, Inc. runs the higher net margin — -3919.6% vs -60892.6%, a 56973.0% gap on every dollar of revenue.
ENvue Medical, Inc. is a medical technology firm specializing in advanced enteral feeding systems and related clinical support solutions. It serves healthcare providers, hospitals and long-term care facilities across North America, focusing on improving safety and efficiency of care for patients requiring enteral nutrition support.
FEED vs PURR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $312.0K | $500.0K |
| Net Profit | $-12.2M | $-304.5M |
| Gross Margin | -118.6% | — |
| Operating Margin | -4748.1% | -57509.2% |
| Net Margin | -3919.6% | -60892.6% |
| Revenue YoY | -29.7% | — |
| Net Profit YoY | -754.6% | — |
| EPS (diluted) | $-28.73 | $-7.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $312.0K | $500.0K | ||
| Q3 25 | $722.0K | — | ||
| Q2 25 | $494.0K | — | ||
| Q1 25 | $1.0M | — | ||
| Q4 24 | $444.0K | — | ||
| Q3 24 | $376.0K | — | ||
| Q2 24 | $817.0K | — | ||
| Q1 24 | $921.0K | — |
| Q4 25 | $-12.2M | $-304.5M | ||
| Q3 25 | $510.0K | — | ||
| Q2 25 | $-4.0M | — | ||
| Q1 25 | $-2.5M | — | ||
| Q4 24 | $-1.4M | — | ||
| Q3 24 | $-998.0K | — | ||
| Q2 24 | $-688.0K | — | ||
| Q1 24 | $-588.0K | — |
| Q4 25 | -118.6% | — | ||
| Q3 25 | 26.2% | — | ||
| Q2 25 | -7.1% | — | ||
| Q1 25 | 36.0% | — | ||
| Q4 24 | 63.7% | — | ||
| Q3 24 | 35.4% | — | ||
| Q2 24 | 52.4% | — | ||
| Q1 24 | 72.1% | — |
| Q4 25 | -4748.1% | -57509.2% | ||
| Q3 25 | -311.2% | — | ||
| Q2 25 | -804.9% | — | ||
| Q1 25 | -180.7% | — | ||
| Q4 24 | -308.6% | — | ||
| Q3 24 | -258.0% | — | ||
| Q2 24 | -82.5% | — | ||
| Q1 24 | -61.7% | — |
| Q4 25 | -3919.6% | -60892.6% | ||
| Q3 25 | 70.6% | — | ||
| Q2 25 | -803.8% | — | ||
| Q1 25 | -243.4% | — | ||
| Q4 24 | -322.3% | — | ||
| Q3 24 | -265.4% | — | ||
| Q2 24 | -84.2% | — | ||
| Q1 24 | -63.8% | — |
| Q4 25 | $-28.73 | $-7.43 | ||
| Q3 25 | $-0.91 | — | ||
| Q2 25 | $-1.03 | — | ||
| Q1 25 | $3.98 | — | ||
| Q4 24 | $-108.94 | — | ||
| Q3 24 | $-3.56 | — | ||
| Q2 24 | $-27.18 | — | ||
| Q1 24 | $2.38 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.2M | $281.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $33.5M | $589.8M |
| Total Assets | $41.1M | $616.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.2M | $281.9M | ||
| Q3 25 | $7.0M | — | ||
| Q2 25 | $4.0M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $752.0K | — | ||
| Q3 24 | $1.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $33.5M | $589.8M | ||
| Q3 25 | $42.5M | — | ||
| Q2 25 | $40.5M | — | ||
| Q1 25 | $35.7M | — | ||
| Q4 24 | $627.0K | — | ||
| Q3 24 | $1.9M | — | ||
| Q2 24 | $2.8M | — | ||
| Q1 24 | $3.5M | — |
| Q4 25 | $41.1M | $616.6M | ||
| Q3 25 | $54.4M | — | ||
| Q2 25 | $51.5M | — | ||
| Q1 25 | $44.1M | — | ||
| Q4 24 | $3.6M | — | ||
| Q3 24 | $4.7M | — | ||
| Q2 24 | $5.7M | — | ||
| Q1 24 | $6.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.7M | — |
| Free Cash FlowOCF − Capex | $-2.7M | — |
| FCF MarginFCF / Revenue | -865.1% | — |
| Capex IntensityCapex / Revenue | 7.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.7M | — | ||
| Q3 25 | $-2.0M | — | ||
| Q2 25 | $-3.4M | — | ||
| Q1 25 | $-1.3M | — | ||
| Q4 24 | $-548.0K | — | ||
| Q3 24 | $-836.0K | — | ||
| Q2 24 | $-553.0K | — | ||
| Q1 24 | $-579.0K | — |
| Q4 25 | $-2.7M | — | ||
| Q3 25 | $-2.0M | — | ||
| Q2 25 | $-3.4M | — | ||
| Q1 25 | $-1.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-555.0K | — | ||
| Q1 24 | $-580.0K | — |
| Q4 25 | -865.1% | — | ||
| Q3 25 | -276.7% | — | ||
| Q2 25 | -685.6% | — | ||
| Q1 25 | -131.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -67.9% | — | ||
| Q1 24 | -63.0% | — |
| Q4 25 | 7.4% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | -3.86× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
